169 related articles for article (PubMed ID: 28588475)
21. Dopamine depletion impairs gait automaticity by altering cortico-striatal and cerebellar processing in Parkinson's disease.
Gilat M; Bell PT; Ehgoetz Martens KA; Georgiades MJ; Hall JM; Walton CC; Lewis SJG; Shine JM
Neuroimage; 2017 May; 152():207-220. PubMed ID: 28263926
[TBL] [Abstract][Full Text] [Related]
22. Basal ganglia dysfunction in idiopathic REM sleep behaviour disorder parallels that in early Parkinson's disease.
Rolinski M; Griffanti L; Piccini P; Roussakis AA; Szewczyk-Krolikowski K; Menke RA; Quinnell T; Zaiwalla Z; Klein JC; Mackay CE; Hu MT
Brain; 2016 Aug; 139(Pt 8):2224-34. PubMed ID: 27297241
[TBL] [Abstract][Full Text] [Related]
23. Dopaminergic pathways and resting-state functional connectivity in Parkinson's disease with freezing of gait.
Steidel K; Ruppert MC; Palaghia I; Greuel A; Tahmasian M; Maier F; Hammes J; van Eimeren T; Timmermann L; Tittgemeyer M; Drzezga A; Pedrosa D; Eggers C
Neuroimage Clin; 2021; 32():102899. PubMed ID: 34911202
[TBL] [Abstract][Full Text] [Related]
24. Gender differences in dopaminergic system dysfunction in de novo Parkinson's disease clinical subtypes.
Boccalini C; Carli G; Pilotto A; Padovani A; Perani D
Neurobiol Dis; 2022 Jun; 167():105668. PubMed ID: 35219854
[TBL] [Abstract][Full Text] [Related]
25. Cognitive performance correlates with the degree of dopaminergic degeneration in the associative part of the striatum in non-demented Parkinson's patients.
Kübler D; Schroll H; Buchert R; Kühn AA
J Neural Transm (Vienna); 2017 Sep; 124(9):1073-1081. PubMed ID: 28643101
[TBL] [Abstract][Full Text] [Related]
26. Reward insensitivity is associated with dopaminergic deficit in rapid eye movement sleep behaviour disorder.
Barber TR; Muhammed K; Drew D; Bradley KM; McGowan DR; Klein JC; Manohar SG; Hu MTM; Husain M
Brain; 2023 Jun; 146(6):2502-2511. PubMed ID: 36395092
[TBL] [Abstract][Full Text] [Related]
27. Gray matter correlates of dopaminergic degeneration in Parkinson's disease: A hybrid PET/MR study using (18) F-FP-CIT.
Choi H; Cheon GJ; Kim HJ; Choi SH; Kim YI; Kang KW; Chung JK; Kim EE; Lee DS
Hum Brain Mapp; 2016 May; 37(5):1710-21. PubMed ID: 26846350
[TBL] [Abstract][Full Text] [Related]
28. Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease.
Bohnen NI; Müller ML; Zarzhevsky N; Koeppe RA; Bogan CW; Kilbourn MR; Frey KA; Albin RL
Brain; 2011 Aug; 134(Pt 8):2358-65. PubMed ID: 21653540
[TBL] [Abstract][Full Text] [Related]
29. Dissociable effects of dopaminergic medications on depression symptom dimensions in Parkinson's disease.
Costello H; Schrag AE; Howard R; Roiser JP
medRxiv; 2023 Jun; ():. PubMed ID: 37425947
[TBL] [Abstract][Full Text] [Related]
30. Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease.
Qamhawi Z; Towey D; Shah B; Pagano G; Seibyl J; Marek K; Borghammer P; Brooks DJ; Pavese N
Brain; 2015 Oct; 138(Pt 10):2964-73. PubMed ID: 26209314
[TBL] [Abstract][Full Text] [Related]
31. Structural connectivity differences in motor network between tremor-dominant and nontremor Parkinson's disease.
Barbagallo G; Caligiuri ME; Arabia G; Cherubini A; Lupo A; Nisticò R; Salsone M; Novellino F; Morelli M; Cascini GL; Galea D; Quattrone A
Hum Brain Mapp; 2017 Sep; 38(9):4716-4729. PubMed ID: 28631404
[TBL] [Abstract][Full Text] [Related]
32. Current coffee consumption is associated with decreased striatal dopamine transporter availability in Parkinson's disease patients and healthy controls.
Wang C; Zhou C; Guo T; Jiaerken Y; Yang S; Xu X; Hu L; Huang P; Xu X; Zhang M
BMC Med; 2023 Jul; 21(1):272. PubMed ID: 37491235
[TBL] [Abstract][Full Text] [Related]
33. Speech difficulties in early de novo patients with Parkinson's disease.
Polychronis S; Niccolini F; Pagano G; Yousaf T; Politis M
Parkinsonism Relat Disord; 2019 Jul; 64():256-261. PubMed ID: 31078401
[TBL] [Abstract][Full Text] [Related]
34. Resting-state fMRI in Parkinson's disease patients with cognitive impairment: A meta-analysis.
Wolters AF; van de Weijer SCF; Leentjens AFG; Duits AA; Jacobs HIL; Kuijf ML
Parkinsonism Relat Disord; 2019 May; 62():16-27. PubMed ID: 30580907
[TBL] [Abstract][Full Text] [Related]
35. 123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson's disease with unilateral symptoms.
Filippi L; Manni C; Pierantozzi M; Brusa L; Danieli R; Stanzione P; Schillaci O
Nucl Med Commun; 2005 May; 26(5):421-6. PubMed ID: 15838424
[TBL] [Abstract][Full Text] [Related]
36. Loss of phosphodiesterase 10A expression is associated with progression and severity in Parkinson's disease.
Niccolini F; Foltynie T; Reis Marques T; Muhlert N; Tziortzi AC; Searle GE; Natesan S; Kapur S; Rabiner EA; Gunn RN; Piccini P; Politis M
Brain; 2015 Oct; 138(Pt 10):3003-15. PubMed ID: 26210536
[TBL] [Abstract][Full Text] [Related]
37. Post mortem studies in Parkinson's disease--is it possible to detect brain areas for specific symptoms?
Jellinger KA
J Neural Transm Suppl; 1999; 56():1-29. PubMed ID: 10370901
[TBL] [Abstract][Full Text] [Related]
38. Thalamic cholinergic innervation and postural sensory integration function in Parkinson's disease.
Müller ML; Albin RL; Kotagal V; Koeppe RA; Scott PJ; Frey KA; Bohnen NI
Brain; 2013 Nov; 136(Pt 11):3282-9. PubMed ID: 24056537
[TBL] [Abstract][Full Text] [Related]
39. Atomoxetine restores the response inhibition network in Parkinson's disease.
Rae CL; Nombela C; Rodríguez PV; Ye Z; Hughes LE; Jones PS; Ham T; Rittman T; Coyle-Gilchrist I; Regenthal R; Sahakian BJ; Barker RA; Robbins TW; Rowe JB
Brain; 2016 Aug; 139(Pt 8):2235-48. PubMed ID: 27343257
[TBL] [Abstract][Full Text] [Related]
40. Loss of integrity and atrophy in cingulate structural covariance networks in Parkinson's disease.
de Schipper LJ; van der Grond J; Marinus J; Henselmans JML; van Hilten JJ
Neuroimage Clin; 2017; 15():587-593. PubMed ID: 28652971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
